Os aceleradores lineares representam a mais importante, prática e versátil produtores de raios-X de alta energia em radioterapia. O comportamento funcional destes equipamentos pode variar devido a defeitos eletrônicos, falhas de componentes ou rupturas mecânicas, ou então podem variar devido ao deterioramento e envelhecimento de seus componentes. A manutenção da qualidade dos tratamentos depende essencialmente da estabilidade dos aceleradores e do controle de qualidade das instituições para monitorar desvios nos parâmetros do feixe. O objetivo deste trabalho consiste em avaliar e analisar a estabilidade do fator de calibração dos aceleradores lineares, bem como os demais parâmetros dosimétricos normalmente incluídos em um programa de controle de qualidade em radioterapia. A média dos fatores de calibração dos aceleradores para o período de aproximadamente quatro anos para os Clinacs 600C e 6EX foram (0,998 ± 0,012) e (0,996 ± 0,014), respectivamente. Para o Clinac 2100CD de 6 MV e 15 MV foi (1,008 ± 0,009) e (1,006 ± 0,010), respectivamente, em um período de aproximadamente quatro anos. Através de análises estatísticas nos três aceleradores lineares verificou-se que os coeficientes de variação dos fatores de calibração apresentaram valores inferiores a 2% o que mostra uma homogeneidade nos dados. Através do cálculo da distribuição normal dos fatores de calibração, verificou-se que para os Clinacs 600C e 2100CD, é esperada uma probabilidade de que em mais de 90% dos casos os valores estejam dentro dos limites aceitáveis segundo o protocolo TG-142, enquanto que para o Clinac 6EX é esperado em torno de 85% uma vez que esse acelerador apresentou diversas trocas de componentes. Os valores do TPR20,10 dos três aceleradores são praticamente constantes e dentro dos limites aceitáveis segundo o protocolo TG-142. Pode-se concluir que um estudo detalhado dos dados do fator de calibração dos aceleradores e do TPR20,10 a partir de um ponto de vista quantitativo, é extremamente útil em um programa de garantia de qualidade. / The linear accelerators represent the most important, practical and versatile source of ionizing radiation in radiotherapy. These functional characteristics influence the geometric and dosimetric accuracy of therapeutic doses applied to patients. The performance of this equipment may vary due to electronic defects, component failures or mechanical breakdowns, or may vary due to the deterioration and aging of components. Maintaining the quality of care depends on the stability of the accelerators and quality control of the institutions to monitor deviations in the parameters of the beam. The aim of this study is to assess and analyze the stability of the calibration factor of linear accelerators, as well as the other dosimetric parameters normally included in a program of quality control in radiotherapy. The average calibration factors of the accelerators for the period of approximately four years for the Clinac 600C and Clinac 6EX were (0,998 ± 0,012) and (0,996 ± 0,014), respectively. For the Clinac 2100CD 6 MV and 15 MV was (1,008 ± 0,009) and (1,006 ± 0,010), respectively, in a period of approximately four years. Statistical analysis of the three linear accelerators was found that the coefficient of variation of calibration factors had values below 2% which shows a consistency in the data. By calculating the normal distribution of calibration factors, we found that for the Clinac 600C and Clinac 2100CD, is an expected probability that more than 90% of cases the values are within acceptable limits according to the TG-142, while for the Clinac 6EX is expected around 85% since this had several exchanges of accelerator components. The values of TPR20,10 of three accelerators are practically constant and within acceptable limits according to the TG-142. It can be concluded that a detailed study of data from the calibration factor of the accelerators and TPR20,10 from a quantitative point of view, is extremely useful in a quality assurance program.

Os aceleradores lineares representam a mais importante, prática e versátil produtores de raios-X de alta energia em radioterapia. O comportamento funcional destes equipamentos pode variar devido a defeitos eletrônicos, falhas de componentes ou rupturas mecânicas, ou então podem variar devido ao deterioramento e envelhecimento de seus componentes. A manutenção da qualidade dos tratamentos depende essencialmente da estabilidade dos aceleradores e do controle de qualidade das instituições para monitorar desvios nos parâmetros do feixe. O objetivo deste trabalho consiste em avaliar e analisar a estabilidade do fator de calibração dos aceleradores lineares, bem como os demais parâmetros dosimétricos normalmente incluídos em um programa de controle de qualidade em radioterapia. A média dos fatores de calibração dos aceleradores para o período de aproximadamente quatro anos para os Clinacs 600C e 6EX foram (0,998 ± 0,012) e (0,996 ± 0,014), respectivamente. Para o Clinac 2100CD de 6 MV e 15 MV foi (1,008 ± 0,009) e (1,006 ± 0,010), respectivamente, em um período de aproximadamente quatro anos. Através de análises estatísticas nos três aceleradores lineares verificou-se que os coeficientes de variação dos fatores de calibração apresentaram valores inferiores a 2% o que mostra uma homogeneidade nos dados. Através do cálculo da distribuição normal dos fatores de calibração, verificou-se que para os Clinacs 600C e 2100CD, é esperada uma probabilidade de que em mais de 90% dos casos os valores estejam dentro dos limites aceitáveis segundo o protocolo TG-142, enquanto que para o Clinac 6EX é esperado em torno de 85% uma vez que esse acelerador apresentou diversas trocas de componentes. Os valores do TPR20,10 dos três aceleradores são praticamente constantes e dentro dos limites aceitáveis segundo o protocolo TG-142. Pode-se concluir que um estudo detalhado dos dados do fator de calibração dos aceleradores e do TPR20,10 a partir de um ponto de vista quantitativo, é extremamente útil em um programa de garantia de qualidade. / The linear accelerators represent the most important, practical and versatile source of ionizing radiation in radiotherapy. These functional characteristics influence the geometric and dosimetric accuracy of therapeutic doses applied to patients. The performance of this equipment may vary due to electronic defects, component failures or mechanical breakdowns, or may vary due to the deterioration and aging of components. Maintaining the quality of care depends on the stability of the accelerators and quality control of the institutions to monitor deviations in the parameters of the beam. The aim of this study is to assess and analyze the stability of the calibration factor of linear accelerators, as well as the other dosimetric parameters normally included in a program of quality control in radiotherapy. The average calibration factors of the accelerators for the period of approximately four years for the Clinac 600C and Clinac 6EX were (0,998 ± 0,012) and (0,996 ± 0,014), respectively. For the Clinac 2100CD 6 MV and 15 MV was (1,008 ± 0,009) and (1,006 ± 0,010), respectively, in a period of approximately four years. Statistical analysis of the three linear accelerators was found that the coefficient of variation of calibration factors had values below 2% which shows a consistency in the data. By calculating the normal distribution of calibration factors, we found that for the Clinac 600C and Clinac 2100CD, is an expected probability that more than 90% of cases the values are within acceptable limits according to the TG-142, while for the Clinac 6EX is expected around 85% since this had several exchanges of accelerator components. The values of TPR20,10 of three accelerators are practically constant and within acceptable limits according to the TG-142. It can be concluded that a detailed study of data from the calibration factor of the accelerators and TPR20,10 from a quantitative point of view, is extremely useful in a quality assurance program.

Recently, there has been interest to integrate VMC++ into the commercial treatment planning system at VCU as another Monte Carlo code option, since it has been shown to increase efficiency dramatically without introducing a significant amount of systematic error. Also, independent validation of VMC++ for photon beams is of interest since this has not been performed previously in literature. This study included several tests required to integrate VMC++. Output factor normalization was performed and found to agree with experiment to within 1% for all field sizes except 1x1 cm2. Geometric validation was successful. Dosimetric validation was performed with respect to DOSXYZnrc on a water phantom, resulting in agreement within statistical uncertainty except for slight differences at the surface of the phantom. Dosimetric comparison was made for a head-and-neck patient case, showing that 5% of the voxels did not agree within 2.8% of maximum dose. The ability of VMC++ to compute dose-to-water was compared to an in-house algorithm and found to agree within statistical uncertainty.

In recent years intensity modulated radiation therapy with photons (xIMRT) has gained attention due to its ability to reduce the dose in the tissues close to the tumour volume. However, this technique also results in a large low dose volume. Electron IMRT (eIMRT) has the potential to reduce the integral dose to the patient due to the dose fall off in the electron depth dose curves. This dose fall off makes it possible to modulate the dose distribution in the direction of the beam by selecting appropriate electron energies. The use of a computer based energy selection method was examined in combination with the IMRT technique to optimise the electron dose distribution. It is clearly illustrated that the energy optimisation procedure reduces the dose to lung and heart in a breast cancer treatment. To shape the multiple electron subfields (beamlets) that are used in eIMRT, an electron multi leaf collimator (eMLC) is needed. However, photons produced in a conventional electron treatment head could penetrate such an added eMLC, thus producing an undesirable dose contribution. The leakage levels normally achieved are acceptable for standard single electron field treatments but could become unacceptably high in eIMRT treatments where a lot of small subfields are combined. To limit this photon contribution, the photon MLC (xMLC) was used to shield off large parts of the photon leakage. The effect of this xMLC shielding on the reduction of photon leakage, the electron beam penumbras, and electron output (dose level), was studied using Monte Carlo methods for different electron treatment head designs. The use of helium as a mean to reduce the electron scatter in the treatment head, and thus the perturbating effect of the xMLC on electron beam penumbra and output, was also investigated. This thesis shows that the effect of the xMLC shielding on the electron beam penumbra and output can be made negligible while still obtaining a significantly reduced x-ray leakage dose contribution. The result is a large gain in radiation protection of the patient and a better dynamic range for the eIMRT dose optimisation. For this optimisation a computer based electron energy selection method was developed and tested on two clinical cases.

<p>The main focus of this work is to improve the existing clinical machine model within the Pinnacle software planning system (at Juravinski Cancer Center, Hamilton, CA). The incident energy fluence spectrum exiting from the accelerator head is considered an important element of the machine model. Relying on the Pinnacle auto modeling function to determine the relative photon fluence spectrum based on percent depth dose curves fitting for various filed sizes, led to different solutions when the process cycle were repeated. This work presents a new method for determining the Pinnacle photon energy fluence spectrum based on 6 MV Varian 21EX machine. A Monte Carlo simulation spectrum based on BEAMnrc code was attenuated to various depths of water. We determine that, the BEAMnrc spectrum attenuated by 15 cm of water gives the closest agreement between the computed and measured depth dose, similar to the clinical machine spectrum.</p> <p>Implementing the novel spectrum into a machine that retained the same modeling parameters as the clinical machine (21ex-JCC) shows a slight better calculation of the output factor. The MLC model parameters were also investigated, however, adjusting the MLC offset table was found to give significant improvements, especially for the small field geometries.</p> <p>The full impact of adjusting the photon energy spectrum, Off-Axis Softening Factor, MLC rounded leaf tip radius and MLC calibration offsets were investigated individually, resulting in a good model parameter fit. Several proposed supplementary setups were created to further assess our model. This include a geometry sensitive to MLC abutment leakage, the calculation of output factors for long and narrow MLC defined fields, and small square MLC and jaws defined fields. A Sun-Point diode detector was used in the measurement of the output factors for its accurate precision at small geometries. In addition, a GAFCHROMIC EBT2 film dosimetry was used in the measurement of the MLC abutment leakage.</p> <p>Our new model shows superior results in comparison to the clinical 21ex-JCC machine model, especially with MLC small field calculations. We conclude that relying on PDD curves and dose profiles validation method in assessing the model might not necessarily lead to the best machine parameters, since these are not sensitive to subtle changes in parameters that have important dosimetric consequences.</p> / Master of Science (MSc)